Commentary
Dr. Leslie receives honoraria or speaker's fees from Merck Frosst Canada, Sanofi-Aventis, and Genzyme Canada Ltd., research support from Merck Frosst Canada, and unrestricted educational grants from Procter & Gamble Pharmaceuticals, Novartis Pharmaceuticals Canada, and Amgen, Canada. Dr. Hans receives honoraria from Perceptive Informatics and Cardea Technology and research support from Hologic, Med-imaps, GE Healthcare, and DAL Foundation. He has stock options or a patent relationship with Synarc, Ascendys, and Med-Imaps.
10.1359/jbmr.090902 About DOI
On Lumpers and Splitters: The FRAX Debate Continues |
| William D. Leslie 1 *, Didier Hans 2 |
| 1Department of Medicine, University of Manitoba, Winnipeg, Canada 2Center of Bone Diseases, Lausanne University Hospital, Lausanne, Switzerland |
| email: William D. Leslie (bleslie@sbgh.mb.ca) |
*Correspondence to William D. Leslie, William D. Leslie, MD, FRCPC, MSc, Department of Medicine (C5121), 409 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada
Dr. Leslie receives honoraria or speaker's fees from Merck Frosst Canada, Sanofi-Aventis, and Genzyme Canada Ltd., research support from Merck Frosst Canada, and unrestricted educational grants from Procter & Gamble Pharmaceuticals, Novartis Pharmaceuticals Canada, and Amgen, Canada. Dr. Hans receives honoraria from Perceptive Informatics and Cardea Technology and research support from Hologic, Med-imaps, GE Healthcare, and DAL Foundation. He has stock options or a patent relationship with Synarc, Ascendys, and Med-Imaps.| Abstract |
| No Abstract. |
| Digital Object Identifier (DOI) |
10.1359/jbmr.090902 About DOI
Journal Information
Information for CONTRIBUTORS
Media
Journal Tools
- Sign up for eTOC Alerts
- Subscription Information
- Recommend to Librarian
Permissions - FAQ
- Contact Us
News RSS feed
ASBMR Resources
